I believe you are right. They don’t seem to have any special pricing power with regards to sustainable tubes. For all the talk about sustainable environment by MNCs, they don’t want to shell out more for sustainable tubes going as per management commentary.
Though I am still invested as i think they are finally walking the talk this quarter by showing double digit revenue growth(driven by oral and recoveryin US and europe), improving americas and europe margins and onbarding new clients in brazil. Also, i think technically the stock has crossed important resistance around 240 with good volumes, so there might be more upside.
| Subscribe To Our Free Newsletter |
